Albert Einstein College of Medicine, shared a post on LinkedIn:
“Congratulations to Marina Konopleva, M.D., on receiving the 2026 Ernest Beutler Lecture and Prize in clinical science from the American Society of Hematology (ASH), one of the field’s highest honors.
Dr. Konopleva is being recognized for pioneering research that advanced targeted therapies for leukemia and helped lay the scientific foundation for the use of venetoclax, a targeted therapy now used to treat several blood cancers. Her work also uncovered why some people with blood cancers develop resistance to BCL2-targeted therapies, helping guide new treatment strategies and improve patient care.
She will deliver the Ernest Beutler Lecture at the 2026 ASH Annual Meeting this December in New Orleans.